Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease (ADEPT)

This study is ongoing, but not recruiting participants.

Study NCT00561392. Last updated on November 20, 2008. Information provided by Novartis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00561392

Locations


Germany
	Novartis Investigative Site
	Munich, Germany

Sponsors and Collaborators

Novartis

Investigators


Study Director:	Novartis Pharmaceuticals	Novartis Pharmaceuticals